Lexington Biosciences, Inc. introduced the following advisors to its team:Jonathan S. Maltz., lead researcher and Chief Scientific Advisor, and has over 16 years of experience designing new devices for assessing vascular function and evaluating these on human subjects. Jeffrey Olgin, a practicing cardiologist and cardiovascular researcher, is the Chief of Cardiology at UCSF and the co-director of the UCSF Heart and Vascular Center. He is an expert in mobile and wearable technology for the prevention, prediction and treatment of heart disease. He is also the principal investigator of the Health eHeart Study, a large-scale cohort for developing and testing mobile and wearable devices. Greg Robertson, is chief of the Emory Heart and Vascular Clinic at Johns Creek Hospital and is the medical director of the cardiac catheterization laboratory and interventional program. He is board certified in Vascular Medicine, Endovascular Medicine, Interventional Cardiology and Cardiovascular Medicine. James Wall, is a practicing Pediatric Surgeon at Stanford University. He is a serial Health Technology entrepreneur who has developed multiple medical devices from idea through commercialization and is also the Assistant Director of the Biodesign Innovation Fellowship for Stanford Biodesign. His current research interests are in the design, development and analysis of health technology as well as the emerging field of surgical endoscopy.